Venture Planning Group (www.VPGMarketResearch.com), an international publishing and management consulting firm, is pleased to announce the completion of a new 880-page report, “The 2011 US Molecular Diagnostics Market” (http://www.vpgmarketresearch.com/molecular-diagnostics). The report is designed to help current suppliers and potential market entrants identify and evaluate major opportunities emerging in the US molecular diagnostics market during this decade.
This report presents a comprehensive analysis of the US molecular diagnostics market, including:
•Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
•An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
•Ten-year test volume and reagent sales forecasts for the following categories:
– Infectious Diseases – Genetic Diseases
– Cancer – Paternity Testing/HLA Typing
– Forensic Testing
•Review of testing methodologies an instrumentation technologies.
•Feature comparison of automated and semiautomated analyzers.
•Sales and market shares of leading suppliers.
•Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
•Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
•Alternative market penetration strategies.
•Potential market entry barriers and risks.
•Business planning issues and concerns.
Contains 880 pages and 37 tables
To review or order this report, please visit
http://www.vpgmarketresearch.com/us-molecular-diagnostic …
To review related reports, please visit
http://www.VPGMarketResearch.com
Contact
Robert Fisher
[email protected]
+1 212 564 2838
